More About Chronic Care Management
Chronic Care Management
The industry is very clear regarding the benefits of Chronic Care Management programs to physicians and their patients. We've compiled 3 reports from key industry players to support CCM claims.
What the CDC and NCHS Say
Reason #1: There is a huge need for CCM
Per CMS 2015:
Nationwide: 67.8% of people 65 yrs and over have 2 or more chronic conditions.
Florida: 74.4% of people 65 yrs and over have 2 or more chronic conditions.
What CMS Says
Reason #2: Many patients qualify for CCM
A chronic disease, as defined by the U.S. National Center for Health Statistics, is a disease lasting three months or longer. Per CMS, the chronic conditions are "expected to last at least 12 months, or until the death of the patient" and "place the patient at significant risk of death, acute exacerbation/ decompensation, or functional decline" Link: cms.gov
A chronic conditions list includes but is not limited to:
Addison's disease
Alzheimer’s Disease and Related Dementia
Arthritis (Osteoarthritis and Rheumatoid)
Asthma
Atrial Fibrillation
Autism Spectrum Disorders
Bronchiectasis
Cancer
Cardiac failure
Cardiomyopathy
Chronic Obstructive Pulmonary Disease
Chronic Pain from multiple disorders
Chronic renal disease
Coronary artery disease
Crohn's disease
Depression
Diabetes
Dysrhythmias
Epilepsy
Glaucoma
Hepatitis
HIV/AIDS
Hyperlipidemia
Hypertension
Ischemic Heart Disease
Multiple sclerosis
Osteoporosis
Parkinson's disease
Schizophrenia and Other Psychotic Disorders
Stroke
Thyroid disorders
Ulcerative colitis
“There were 1.9 million Medicare hospital readmissions in 2010. Medicare beneficiaries with two or more chronic conditions accounted for almost all (98%) of these readmissions.”
What Independent Research Says
Reason #3: CCM is a huge source of untapped healthcare cost Benefits
Mathematica Policy Research developed a study in 2017 discussing the impact of chronic care management services on the costs of healthcare. Download the report to see for yourself the power of implementing a program for your patients.
“We found that the average rate of growth in estimated Medicare per-beneficiary-per-month (PBPM) expenditures for CCM beneficiaries relative to the comparison beneficiaries decreased in the 12- and 18-month follow-up periods — $28 in the 12-month follow-up period and $74 in the 18-month follow-up period.”
